Literature DB >> 16417850

What is attention-deficit hyperactivity disorder (ADHD)?

Lydia Furman1.   

Abstract

Attention-deficit hyperactivity disorder (ADHD) is described as the most common neurobehavioral condition of childhood. We raise the concern that ADHD is not a disease per se but rather a group of symptoms representing a final common behavioral pathway for a gamut of emotional, psychological, and/or learning problems. Increasing numbers of children, especially boys, are diagnosed with ADHD and treated with stimulant medications according to a simplified approach. Methodical review of the literature, however, raised concerning issues. "Core" ADHD symptoms of inattentiveness, hyperactivity and impulsivity are not unique to ADHD. Rates of "comorbid" psychiatric and learning problems, including depression and anxiety, range from 12 to 60%, with significant symptom overlap with ADHD, difficulties in diagnosis, and evidence-based treatment methods that do not include stimulant medications. No neuropsychologic test result is pathognomic for ADHD, and structural and functional neuroimaging studies have not identified a unique etiology for ADHD. No genetic marker has been consistently identified, and heritability studies are confounded by familial environmental factors. The validity of the Conners' Rating Scale-Revised has been seriously questioned, and parent and teacher "ratings" of school children are frequently discrepant, suggesting that use of subjective informant data via scale or interview does not form an objective basis for diagnosis of ADHD. Empiric diagnostic trials of stimulant medication that produce a behavioral response have been shown not to distinguish between children with and without "ADHD." In summary, the working dogma that ADHD is a disease or neurobehavioral condition does not at this time hold up to scrutiny of evidence. Thorough evaluation of symptomatic children should be individualized, and include assessment of educational, psychologic, psychiatric, and family needs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16417850     DOI: 10.1177/08830738050200121301

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  10 in total

1.  Differential brain activation during response inhibition in bipolar and attention-deficit hyperactivity disorders.

Authors:  Michael A Cerullo; Caleb M Adler; Martine Lamy; James C Eliassen; David E Fleck; Stephen M Strakowski; Melissa P DelBello
Journal:  Early Interv Psychiatry       Date:  2009-08       Impact factor: 2.732

2.  The Moderating Effect of Physical Activity on the Association Between ADHD Symptoms and Peer Victimization in Middle Childhood.

Authors:  Tarrah B Mitchell; John L Cooley; Spencer C Evans; Paula J Fite
Journal:  Child Psychiatry Hum Dev       Date:  2016-12

Review 3.  The Role of Nutritional Supplements in the Treatment of ADHD: What the Evidence Says.

Authors:  Klaus W Lange; Joachim Hauser; Katharina M Lange; Ewelina Makulska-Gertruda; Yukiko Nakamura; Andreas Reissmann; Yuko Sakaue; Tomoyuki Takano; Yoshihiro Takeuchi
Journal:  Curr Psychiatry Rep       Date:  2017-02       Impact factor: 5.285

4.  Attention deficit hyperactivity disorder: concordance of the adolescent version of the Composite International Diagnostic Interview Version 3.0 (CIDI) with the K-SADS in the US National Comorbidity Survey Replication Adolescent (NCS-A) supplement.

Authors:  Jennifer Greif Green; Shelli Avenevoli; Matthew Finkelman; Michael J Gruber; Ronald C Kessler; Kathleen R Merikangas; Nancy A Sampson; Alan M Zaslavsky
Journal:  Int J Methods Psychiatr Res       Date:  2010-03       Impact factor: 4.035

Review 5.  Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.

Authors:  Donna Gillies; John Kh Sinn; Sagar S Lad; Matthew J Leach; Melissa J Ross
Journal:  Cochrane Database Syst Rev       Date:  2012-07-11

6.  Patterns of comorbidity, functioning, and service use for US children with ADHD, 2007.

Authors:  Kandyce Larson; Shirley A Russ; Robert S Kahn; Neal Halfon
Journal:  Pediatrics       Date:  2011-02-07       Impact factor: 7.124

7.  The history of attention deficit hyperactivity disorder.

Authors:  Klaus W Lange; Susanne Reichl; Katharina M Lange; Lara Tucha; Oliver Tucha
Journal:  Atten Defic Hyperact Disord       Date:  2010-11-30

8.  SPECT Functional Neuroimaging Distinguishes Adult Attention Deficit Hyperactivity Disorder From Healthy Controls in Big Data Imaging Cohorts.

Authors:  Daniel G Amen; Theodore A Henderson; Andrew Newberg
Journal:  Front Psychiatry       Date:  2021-11-24       Impact factor: 4.157

Review 9.  Overview of Attention Deficit Hyperactivity Disorder in Young Children.

Authors:  Ajay Singh; Chia Jung Yeh; Nidhi Verma; Ajay Kumar Das
Journal:  Health Psychol Res       Date:  2015-04-13

10.  The effect of methylphenidate-OROS<sup>®</sup> on the narrative ability of children with attention-deficit hyperactivity disorder.

Authors:  Tessa L Rausch; Diane L Kendall; Sara T Kover; Elizabeth M Louw; Ursula L Zsilavecz; Anita Van der Merwe
Journal:  S Afr J Commun Disord       Date:  2017-02-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.